
MBX Biosciences, Inc. Common Stock
MBX Biosciences, Inc. Common Stock(MBX)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
mbx · 股价预测 · 7 位分析师(近3月)· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 7 位华尔街分析师
Buy
7 位分析师
共识
评级分布
12 个月目标价
High
$88.00
Consensus
$68.80
+127.2% upside
Low
$56.00
Median: $70 · Last Close: $30.28
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$68.80
127.2% upside
High Target
$88
190.6%
Low Target
$56
84.9%
Current Price
$30.28
as of today
Based on analyst price targets, the MBX stock price prediction for the next 12 months ranges from $56 to $88. The consensus MBX price forecast of $68.80 implies 127.2% upside from the current price of $30.28.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $28.77 | ↓ 5.00% |
1-day model range: $28.49–$29.04. Peak: $29.04 (-5.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MBX · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-12 | Barclays | Maintains | Overweight→Overweight |
| 2026-05-12 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-05-11 | Truist Securities | Maintains | Buy→Buy |
| 2026-01-16 | Guggenheim | Maintains | Buy→Buy |
| 2025-12-19 | Stifel | Maintains | Buy→Buy |
| 2025-11-10 | Guggenheim | Maintains | Buy→Buy |
| 2025-09-24 | Mizuho | Maintains | Outperform→Outperform |
| 2025-09-23 | Oppenheimer | Maintains | Outperform→Outperform |
| 2025-09-23 | Guggenheim | Maintains | Buy→Buy |
| 2025-04-10 | Guggenheim | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on MBX Biosciences, Inc. Common Stock (MBX) stock. Of the recent 10 rating actions, 0 were upgrades and 0 were downgrades. 7 analysts currently cover MBX.
分析师推荐趋势
MBX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 3 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$0M
EPS This Year
$-2.80
EPS Next Year
$-3.91
↑ 39.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast MBX EPS of $-2.80 for the current fiscal year, based on estimates from 8 analysts. The MBX revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
MBX 股价预测由两类独立数据源支撑:来自 7 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。MBX 的共识目标价为 $68.80(+127.2% 上行空间),分析师共识为 Buy。
MBX 的短期预测(明日)为 $28.77(-5.00%)。
MBX Biosciences, Inc. Common Stock 在 NASDAQ 上市,代码 MBX。MBX 在 2027 年的整体展望偏积极,在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
MBX 预测 · 8 个问题根据 7 位华尔街分析师,MBX 的 12 个月平均目标价为 $68.80,最高 $88.00、最低 $56.00。若有图表,中位目标价可在上方查看。相对当前价 $30.28,隐含约 +127.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.